XML 21 R6.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
Total
Common Stock [Member]
Additional Paid in Capital [Member]
Earnings Less than Distributions [Member]
Accumulated Other Comprehensive (Loss) Income [Member]
Noncontrolling Interest [Member]
Consolidated Joint Ventures [Member]
Noncontrolling Interest [Member]
Consolidated Real Estate Related Funds [Member]
Noncontrolling Interest [Member]
Operating Partnership [Member]
Beginning balance at Dec. 31, 2019 $ 4,630,962,000 $ 2,274,000 $ 4,133,184,000 $ (349,557,000) $ (171,000) $ 360,778,000 $ 72,396,000 $ 412,058,000
Common stock, shares outstanding at Dec. 31, 2019   227,432,000            
Net (loss) income (19,196,000)     (24,704,000)   9,257,000 (1,450,000) (2,299,000)
Common shares issued upon redemption of common units   $ 51,000 85,659,000          
Common shares issued upon redemption of common units, shares   5,150,000            
Redemption of minority interest in operating partnerships               (85,710,000)
Common shares issued under Omnibus share plan, net of shares withheld for taxes (332,000) $ 1,000   (333,000)        
Common shares issued under Omnibus share plan, net of shares withheld for taxes   48,000            
Repurchases of common shares (120,000,000) $ (138,000) (119,862,000)          
Repurchases of common shares, shares   (13,813,158)            
Dividends and distributions (89,603,000)     (81,799,000)       (7,804,000)
Contributions from noncontrolling interests 11,555,000         3,500,000 8,055,000  
Distributions to noncontrolling interests (12,717,000)         (12,717,000)    
Pro rata share of other comprehensive income (loss) of unconsolidated joint ventures (13,894,000)       (12,620,000)   16,000 (1,290,000)
Amortization of equity awards 19,386,000   1,318,000         18,068,000
Sale of a 10.0% interest in 1633 Broadway 109,573,000   33,230,000     76,343,000    
Reallocation of noncontrolling interest     (13,356,000)         13,356,000
Ending balance at Dec. 31, 2020 4,515,734,000 $ 2,188,000 4,120,173,000 (456,393,000) (12,791,000) 437,161,000 79,017,000 346,379,000
Common stock, shares outstanding at Dec. 31, 2020   218,817,000            
Net (loss) income 2,059,000     (20,354,000)   21,538,000 2,893,000 (2,018,000)
Common shares issued upon redemption of common units   $ 1,000 960,000         (961,000)
Common shares issued upon redemption of common units, shares   59,000            
Common shares issued under Omnibus share plan, net of shares withheld for taxes (235,000) $ 1,000   (236,000)        
Common shares issued under Omnibus share plan, net of shares withheld for taxes   116,000            
Dividends and distributions (67,578,000)     (61,310,000)       (6,268,000)
Contributions from noncontrolling interests 121,000         121,000    
Distributions to noncontrolling interests (30,539,000)         (30,539,000)    
Change in value of interest rate swaps 6,857,000       6,237,000     620,000
Pro rata share of other comprehensive income (loss) of unconsolidated joint ventures 9,565,000       8,692,000   15,000 858,000
Amortization of equity awards 18,777,000   1,221,000         17,556,000
Reallocation of noncontrolling interest     55,000         (55,000)
Other 271,000   271,000 (552,000)   552,000    
Ending balance at Dec. 31, 2021 $ 4,455,032,000 $ 2,190,000 4,122,680,000 (538,845,000) 2,138,000 428,833,000 81,925,000 356,111,000
Common stock, shares outstanding at Dec. 31, 2021 218,991,795 218,992,000            
Net (loss) income $ (28,197,000)     (36,403,000)   13,981,000 (3,342,000) (2,433,000)
Common shares issued upon redemption of common units   $ 79,000 128,664,000         (128,743,000)
Common shares issued upon redemption of common units, shares   7,844,000            
Common shares issued under Omnibus share plan, net of shares withheld for taxes (284,000)     (284,000)        
Common shares issued under Omnibus share plan, net of shares withheld for taxes   94,000            
Repurchases of common shares (65,000,000) $ (104,000) (64,896,000)          
Repurchases of common shares, shares   (10,370,610)            
Dividends and distributions (74,155,000)     (68,560,000)       (5,595,000)
Contributions from noncontrolling interests 3,257,000           3,257,000  
Distributions to noncontrolling interests (40,699,000)         (40,699,000)    
Change in value of interest rate swaps 31,839,000       29,194,000     2,645,000
Pro rata share of other comprehensive income (loss) of unconsolidated joint ventures 18,485,000       16,964,000     1,521,000
Amortization of equity awards 19,189,000   1,302,000         17,887,000
Consolidation of real estate related fund investments that were previously unconsolidated 91,535,000           91,535,000  
Reallocation of noncontrolling interest     (1,589,000)         1,589,000
Other (236,000)     (239,000)   3,000    
Ending balance at Dec. 31, 2022 $ 4,410,766,000 $ 2,165,000 $ 4,186,161,000 $ (644,331,000) $ 48,296,000 $ 402,118,000 $ 173,375,000 $ 242,982,000
Common stock, shares outstanding at Dec. 31, 2022 216,559,406 216,559,000